Evaluation of anticancer efficacy of survivin si-RNA functionalized combined drug-loaded mesoporous silica nanoparticles in a lung cancer mouse model
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-024-03751-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Fahima Dilnawaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Centurion University of Technology and Management, Bhubaneswar, Odisha, 752050, India. fahimadilnawaz@gmail.com. Hauptthemen laut MEDLINE: Survivin, Silicon Dioxide, Lung Neoplasms, Nanoparticles. Die Arbeit nennt 73 Literaturangaben. Gefördert von: Department of Science and Technology, Govertment of India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology, Centurion University of Technology and Management, Bhubaneswar, Odisha, 752050, India. fahimadilnawaz@gmail.com.
- Institute of Life Sciences, Nalco Square, Bhubaneswar, Odisha, 751023, India. fahimadilnawaz@gmail.com.
- Institute of Life Sciences, Nalco Square, Bhubaneswar, Odisha, 751023, India.
Förderung
- Department of Science and Technology, Govertment of India
Zitieren
APA
Dilnawaz, F., Jena, S., & Nayak, S. (2025). Evaluation of anticancer efficacy of survivin si-RNA functionalized combined drug-loaded mesoporous silica nanoparticles in a lung cancer mouse model. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03751-y
Vancouver
Dilnawaz F, Jena S, Nayak S. Evaluation of anticancer efficacy of survivin si-RNA functionalized combined drug-loaded mesoporous silica nanoparticles in a lung cancer mouse model. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03751-y
BibTeX
@article{Dilnawaz2025,
author = {Dilnawaz, Fahima and Jena, Sarita and Nayak, Sunita},
title = {Evaluation of anticancer efficacy of survivin si-RNA functionalized combined drug-loaded mesoporous silica nanoparticles in a lung cancer mouse model},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-024-03751-y}
}
EUVIMED